[Mindray Announces Up to $200 Million Share Repurchase Program Shenzhen, China November 4, 2013 Mindray Medical International Limited (Mindray or Company, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved a share repurchase program. The program is authorized to be in effect starting from today and]
[Mindray Announces Up to $200 Million Share Repurchase Program Shenzhen, China November 4, 2013 Mindray Medical International Limited (Mindray or Company, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved a share repurchase program. The program is authorized to be in effect starting from today and]
[Mindray Announces Third Quarter 2013 Financial Results Shenzhen, China November 4, 2013 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September 30, 2013. Highlights for Third Quarter 2013 Net revenues increased 15.3% year-over-year to $296.3 million. International]
[Mindray Announces Third Quarter 2013 Financial Results Shenzhen, China November 4, 2013 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September 30, 2013. Highlights for Third Quarter 2013 Net revenues increased 15.3% year-over-year to $296.3 million. International]
[Mindray Announces Up to $200 Million Share Repurchase Program Shenzhen, China November4, 2013 Mindray Medical International Limited (Mindray ormpany, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved a share repurchase program. The program is authorized to be in effect starting from today]
[Mindray Announces Up to $200 Million Share Repurchase Program Shenzhen, China November4, 2013 Mindray Medical International Limited (Mindray ormpany, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved a share repurchase program. The program is authorized to be in effect starting from today]
[Mindray Announces Third Quarter 2013 Financial Results Shenzhen, China November4, 2013 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September30, 2013. Highlights for Third Quarter 2013 Net revenuesreased 15.3% year-over-year to $296.3 million. Internationalles grew]
[Mindray Announces Third Quarter 2013 Financial Results Shenzhen, China November4, 2013 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September30, 2013. Highlights for Third Quarter 2013 Net revenuesreased 15.3% year-over-year to $296.3 million. Internationalles grew]
[UTStarcom Announces Withdrawal of Non-Binding Going Private Proposal and Appointment of New Director Beijing, November 1, 2013 UTStarcom Holdings Corp. (UTStarcom or the Company) (NASDAQ: UTSI), a leading provider of media operational support services and broadband equipment products and services, today announced that the Special Committee of its Board of Directors has received a notice from one of the]
[UTStarcom Announces Withdrawal of Non-Binding Going Private Proposal and Appointment of New Director Beijing, November 1, 2013 UTStarcom Holdings Corp. (UTStarcom or the Company) (NASDAQ: UTSI), a leading provider of media operational support services and broadband equipment products and services, today announced that the Special Committee of its Board of Directors has received a notice from one of the]
